Garibaldi L R, Picco P, Magier S, Chevli R, Aceto T
Department of Pediatrics and Adolescent Medicine, St. Louis University, Missouri.
J Clin Endocrinol Metab. 1991 Apr;72(4):888-98. doi: 10.1210/jcem-72-4-888.
To determine the diagnostic potential of a highly sensitive immunoradiometric assay (IRMA) for LH in children with normal puberty or altered tempo of sexual maturation, we compared serum LH levels by IRMA (LH IRMA) and standard RIA (LH RIA) in children with idiopathic precocious thelarche (IPT; n = 6), idiopathic premature adrenarche (IPA; n = 14), central precocious puberty (CPP; n = 15), and constitutional delay of puberty (DP; n = 15), and 160 control children (79 males and 81 females). Subjects in the latter group were staged, according to their genital or breast development, as early prepubertal (P1E; age, less than 8 yr), late prepubertal (P1L; 8-12 yr), or stage II-V (P2-P5; n = 22-34 for each subgroup). Serum LH IRMA levels in P1E, IPT, and IPA children were either undetectable (95% of subjects less than 0.25 IU/L) or barely detectable (5% of subjects, less than or equal to 0.5 IU/L). Serum LH IRMA levels were greater than 0.5 IU/L in 38% of P1L (mean +/- SD for the group, 1.0 +/- 1.3 IU/L) and 57% of P2 (1.4 +/- 1.3 IU/L); they were greater than 1.0 IU/L in 100% of P3 (2.6 +/- 1.3 IU/L), P4 (3.9 +/- 2 IU/L), and P5 (8.6 +/- 4 IU/L) children. Comparison of serum LH levels between contiguous pubertal stages showed significantly higher LH IRMA concentrations in P3 vs. P1E, P4 vs. P2, P5 vs. P4 (all P less than 0.001), and P3 vs. P1L (P less than 0.05). In contrast, LH RIA values were not significantly different in P1E (2.0 +/- 0.6 IU/L), P1L (2.3 +/- 0.6 IU/L), P2 (2.7 +/- 0.9 IU/L), P3 (3.2 +/- 1.3 IU/L), and P4 (3.7 +/- 2.2 IU/L), although they were higher in P5 (6.8 +/- 4 IU/L) than in P4 (P less than 0.001). From P1E to P5 LH IRMA levels increased 38-fold in females and 21-fold in males, while LH RIA increased 4- and 2.1-fold, respectively. Serum LH IRMA correlated significantly with serum testosterone levels in boys from P1L to P5 (r = 0.76; P less than 0.001), while LH RIA levels did not (r = 0.18). Serum LH IRMA concentrations were above the prepubertal range (greater than 0.5 IU/L) in 67% of children with CPP (group average, 1.8 +/- 1.4 IU/L) and 87% of children with DP (1.6 +/- 1.4 IU/L).(ABSTRACT TRUNCATED AT 400 WORDS)
为了确定高敏免疫放射分析(IRMA)检测促黄体生成素(LH)在青春期发育正常或性成熟节奏改变儿童中的诊断潜力,我们比较了特发性乳房早发育(IPT;n = 6)、特发性肾上腺功能早现(IPA;n = 14)、中枢性性早熟(CPP;n = 15)、青春期体质性延迟(DP;n = 15)患儿以及160名对照儿童(79名男性和81名女性)血清LH水平的免疫放射分析(LH IRMA)结果和标准放射免疫分析(LH RIA)结果。后一组受试者根据其生殖器或乳房发育情况分为青春期前早期(P1E;年龄小于8岁)、青春期前晚期(P1L;8 - 12岁)或II - V期(P2 - P5;每个亚组n = 22 - 34)。P1E、IPT和IPA患儿的血清LH IRMA水平要么检测不到(95%的受试者低于0.25 IU/L),要么勉强可检测到(5%的受试者,小于或等于0.5 IU/L)。P1L组38%的患儿(该组均值±标准差为1.0±1.3 IU/L)和P2组57%的患儿(1.4±1.3 IU/L)血清LH IRMA水平大于0.5 IU/L;P3组(2.6±1.3 IU/L)、P4组(3.9±2 IU/L)和P5组(8.6±4 IU/L)100%的患儿血清LH IRMA水平大于1.0 IU/L。相邻青春期阶段血清LH水平比较显示,P3期与P1E期、P4期与P2期、P5期与P4期(均P < 0.001)以及P3期与P1L期(P < 0.05)的LH IRMA浓度显著更高。相比之下,P1E期(2.0±0.6 IU/L)、P1L期(2.3±0.